Abstract:Abstract INTRODUCTION Exosomes have emerged as key local and systemic immune modulators in glioma, particularly in tumors with an IDH mutation. However, the exact mechanism by which these vehicles communicate with the tumor immune microenvironment warrants further exploration. We sought to identify exosomal miRNA differences in discrete genomic subsets in glioma and predict potential mRNA targets in tumor immune cell populations. METHODS Exosomes were isolated from IDH wild-type (IDHwt) and IDH mutant (IDHm) glioma organoids using ultracentrifugation. Nanoparticle Tracking Analysis and western blot were used to validate exosome capture. Exosomal miRNA was sequenced using the Illumina Novaseq platform and targets were predicted using TargetScan. Peripheral blood mononuclear cells (PBMCs) were isolated from glioma patients and processed for scRNA-seq. RESULTS The characteristics of isolated exosomes were consistent with previously published data. Six miRNAs were over-expressed in IDHm exosomes compared to IDHwt. Interestingly, none of these miRNAs were significantly up-regulated in IDHm tumor tissue. Comparison between predicted targets of IDHm exosome miRNA and scRNA-seq of circulating tumor PBMCs identified a set of expressed genes involved in the FOXO pathway, which is implicated in microglia activation and polarization. Furthermore, scRNA-seq analysis showed that the FOXO3 pathway is activated in CD14+AREG+ monocytes and CD14+RNA-lo monocytes, which are two cell populations that are fractionally down-regulated in IDHm glioma. CONCLUSION Our group and others have defined mutation-dependent mechanisms of immunosuppression in glioma. Here, we characterized the effects of tumor mutational status on exosome miRNA cargo and conducted a miRNA-mRNA network analysis to identify potential targets in tumor-associated myeloid cells. Our results suggest that exosomes may play a role in suppressing specific populations of monocytes via the FOXO pathway in an IDH-mutation dependent manner. This data sets the stage for mechanistic exploration of glioma exosomes on peripheral myeloid tumor immunity.

Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells

The Dual Role of Glioma Exosomal Micrornas: Glioma Eliminates Tumor Suppressor Mir-1298-5p Via Exosomes to Promote Immunosuppressive Effects of MDSCs

Mir-3184-3p Enriched in Cerebrospinal Fluid Exosomes Contributes to Progression of Glioma and Promotes M2-like Macrophage Polarization.

Glioma Exosomes Mediate the Expansion and Function of Myeloid-Derived Suppressor Cells Through Microrna-29A/hbp1 and Microrna-92A/prkar1a Pathways.

Hypoxic Glioma-Derived Exosomes Deliver Microrna-1246 to Induce M2 Macrophage Polarization by Targeting TERF2IP Via the STAT3 and NF-κB Pathways

Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion

Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression

Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways

Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop

Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway

Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically

TMIC-22. IDENTIFICATION OF EXOSOME MIRNA-MRNA INTERACTIONS IN THE GLIOMA TUMOR IMMUNE MICROENVIRONMENT

Exosomal Mir-155-5p Derived from Glioma Stem-Like Cells Promotes Mesenchymal Transition Via Targeting ACOT12

miR‐3184‐3p enriched in CSF exosomes contribute to progression of glioma and promotes M2‐like macrophage polarization

MicroRNA-1592 in the Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Inhibits the Glioma Development In Vivo and In Vitro

Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia

Glioblastoma stem cell-derived exosomal miR-374b-3p promotes tumor angiogenesis and progression through inducing M2 macrophages polarization

Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction

Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2

Hypoxic Cancer-Secreted Exosomal Mir-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-Like Factor 2 and 4